Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Harpoon Therapeutics, Inc. HARP

Full chart Compare
Set alert

Price alert · HARP

All alert types
23.01 0.00 (+0.00%)

At closeMar 8, 2024, 4:00 PM EST

22.99 Day range 23.02

52-week range unavailable

Financial health

Altman Z-Score

0.36 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2016: -112×FY 2017: -7.6×FY 2018: -11.8×FY 2019: -6.2×FY 2020: -9.0×FY 2021: -1.5×FY 2022: -0.4×
FY 2016 5y median -6.2× FY 2022
P/S 0.8×
FY 2016: 0.0×FY 2017: 180×FY 2018: 68.0×FY 2019: 55.7×FY 2020: 23.8×FY 2021: 10.3×FY 2022: 0.8×
FY 2016 5y median 23.8× FY 2022
P/B 4.5×
FY 2016: -122×FY 2017: -4.7×FY 2018: -6.0×FY 2019: 3.4×FY 2020: 7.7×FY 2021: 4.2×FY 2022: 4.5×
FY 2016 5y median 4.2× FY 2022
P/FCF -0.3×
FY 2016: -112×FY 2017: -227×FY 2018: -11.6×FY 2019: -50.2×FY 2020: -44.7×FY 2021: -2.0×FY 2022: -0.3×
FY 2016 5y median -11.6× FY 2022
EV/EBITDA 0.2×
FY 2016: -117×FY 2017: -6.1×FY 2018: -8.5×FY 2019: -3.1×FY 2020: -8.3×FY 2021: -1.8×FY 2022: 0.2×
FY 2016 5y median -3.1× FY 2022
EV/Sales -0.4×
FY 2016: 0.0×FY 2017: 139×FY 2018: 49.1×FY 2019: 31.4×FY 2020: 23.4×FY 2021: 8.9×FY 2022: -0.4×
FY 2016 5y median 23.4× FY 2022
FCF Yield -371.8%
FY 2016: -0.9%FY 2017: -0.4%FY 2018: -8.6%FY 2019: -2.0%FY 2020: -2.2%FY 2021: -50.2%FY 2022: -371.8%
FY 2016 5y median -8.6% FY 2022

Profitability

Gross Margin 90.3%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 88.8%FY 2022: 90.3%
FY 2016 5y median 100.0% FY 2022
Operating Margin -214.1%
FY 2016: 0.0%FY 2017: -2334.5%FY 2018: -583.7%FY 2019: -1007.5%FY 2020: -294.3%FY 2021: -493.6%FY 2022: -214.1%
FY 2016 5y median -493.6% FY 2022
Net Margin -210.4%
FY 2016: 0.0%FY 2017: -2377.1%FY 2018: -576.1%FY 2019: -900.1%FY 2020: -265.9%FY 2021: -703.6%FY 2022: -210.4%
FY 2016 5y median -576.1% FY 2022
ROE -1243.5%
FY 2016: 109.2%FY 2017: 62.5%FY 2018: 51.2%FY 2019: -55.2%FY 2020: -86.1%FY 2021: -286.6%FY 2022: -1243.5%
FY 2016 5y median -86.1% FY 2022
ROIC -285.5%
FY 2016: -163.1%FY 2017: -66.2%FY 2018: -30.6%FY 2019: -35.1%FY 2020: -38.2%FY 2021: -119.2%FY 2022: -285.5%
FY 2016 5y median -38.2% FY 2022
ROA -91.1%
FY 2016: -136.0%FY 2017: -52.8%FY 2018: -26.7%FY 2019: -29.4%FY 2020: -27.0%FY 2021: -107.1%FY 2022: -91.1%
FY 2016 5y median -29.4% FY 2022

Growth (YoY)

Revenue 34.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 570.9%FY 2019: 21.6%FY 2020: 202.0%FY 2021: 35.6%FY 2022: 34.9%
FY 2016 FY 2022
Operating Income 41.5%
FY 2016: 0.0%FY 2017: -48.3%FY 2018: -67.7%FY 2019: -109.9%FY 2020: 11.8%FY 2021: -127.4%FY 2022: 41.5%
FY 2016 FY 2022
EPS (diluted) 60.8%
FY 2016: 0.0%FY 2017: -1371.9%FY 2018: 35.7%FY 2019: -108.8%FY 2020: 22.5%FY 2021: -178.5%FY 2022: 60.8%
FY 2016 FY 2022
Free Cash Flow 26.8%
FY 2016: 0.0%FY 2017: 95.1%FY 2018: -4853.5%FY 2019: 76.9%FY 2020: -45.1%FY 2021: -1214.7%FY 2022: 26.8%
FY 2016 FY 2022

Financial Health

Current Ratio 1.0×
FY 2016: 2.1×FY 2017: 4.3×FY 2018: 7.6×FY 2019: 6.7×FY 2020: 2.7×FY 2021: 2.3×FY 2022: 1.0×
FY 2016 5y median 2.7× FY 2022
Quick Ratio 1.0×
FY 2016: 2.1×FY 2017: 4.3×FY 2018: 7.6×FY 2019: 6.7×FY 2020: 2.7×FY 2021: 2.3×FY 2022: 1.0×
FY 2016 5y median 2.7× FY 2022
Debt / Equity 3.0×
FY 2016: -0.2×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 3.0×
FY 2016 5y median 0.2× FY 2022
Net Debt / EBITDA 0.5×
FY 2016: -0.1×FY 2017: 1.8×FY 2018: 3.3×FY 2019: 2.4×FY 2020: 0.2×FY 2021: 0.3×FY 2022: 0.5×
FY 2016 5y median 0.5× FY 2022
Interest Coverage 0.0×
FY 2016: -42.7×FY 2017: -58.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2016 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31